A Case Series of Stent Thrombosis During the COVID-19 Pandemic

Prieto-Lobato, Alicia; Ramos-Martínez, Raquel; Vallejo-Calcerrada, Nuria; Corbí-Pascual, Miguel; Córdoba-Soriano, Juan G.

doi:10.1016/j.jaccas.2020.05.024

Cited by 48 publications

(55 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 17 In this regard, published reports indicate the occurrence of all types of stent thrombosis, ranging from acute to very late. 17 , 34 , 35 , 36 , 37 As previously mentioned, its mechanism triggers an increase in thrombogenicity due to severe systemic inflammation, followed by activation of coagulation cascade and platelet inhibition in patients with COVID-19. Nevertheless, sufficient attention should be paid to the implantation of previous generations of drug eluting stents (first generation) in late and very late cases, stent malposition and under-expansion and edge dissection in acute and subacute cases as well as clinical risk factors such as chronic renal failure.…”

Section: Stent Thrombosismentioning

confidence: 96%

“…Nevertheless, sufficient attention should be paid to the implantation of previous generations of drug eluting stents (first generation) in late and very late cases, stent malposition and under-expansion and edge dissection in acute and subacute cases as well as clinical risk factors such as chronic renal failure. 34 It is noteworthy that the prescription of the appropriate dual antiplatelet therapy combination is also a subject of debate in patients with COVID-19. Some reports support ticagrelor as a potent and reversible P2Y12 inhibitor, 36 while some others prefer the use of prasugrel owing to its high potency and lack of interaction with COVID-19 therapies.…”

Section: Stent Thrombosismentioning

confidence: 99%

“…Some reports support ticagrelor as a potent and reversible P2Y12 inhibitor, 36 while some others prefer the use of prasugrel owing to its high potency and lack of interaction with COVID-19 therapies. 34 , 37 …”

Section: Stent Thrombosismentioning

confidence: 99%

See 2 more Smart Citations

A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction

Kermani-Alghoraishi

2021

Current Problems in Cardiology

View full text Add to dashboard Cite

As the COVID-19 pandemic continues, more information on the non-respiratory effects of the coronavirus is obtained. Cardiovascular complications, especially acute coronary syndromes, are rare. However, they prove to be effective factors in the mortality rate of COVID-19 subjects. Acute ST-elevation myocardial infarction with a special angiographic pattern in the form of extensive and multi-vessel thrombosis, regardless of atherosclerotic plaques, has posed a new therapeutic challenge. This has been associated with an increase in the incidence of stent thrombosis. Hypercoagulation, due to severe inflammation, is the main pathology of this phenomenon. Technically, percutaneous coronary intervention with aspiration thrombectomy and injectable antiplatelet are the mainstay of treatment for these patients. In addition, it is vital that appropriate antiplatelet and ischemia treatment after the intervention be taken into account.

show abstract

Section: Stent Thrombosismentioning

confidence: 96%

Section: Stent Thrombosismentioning

confidence: 99%

See 1 more Smart Citation

A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction

Kermani-Alghoraishi

2021

Current Problems in Cardiology

View full text Add to dashboard Cite

show abstract

“…Restenosis has been observed in COVID-19 cases; however, none of the reports showed such acute restenosis within minutes. Another study by Prieto-Lobato et al provided recommendations for maintaining the same antithrombotic treatment and PCI for ACS in COVID-19 patients as for COVID-19 negative patients [ 2 ].…”

Section: Discussionmentioning

confidence: 99%

“…During the ongoing coronavirus disease 2019 (COVID-19), a variety of cardiovascular and thromboembolic manifestations have been reported in the literature. Cardiovascular or thromboembolic complications can include acute coronary syndrome (ACS) with new ischemic events and can occur in stent restenosis when using dual antiplatelet therapy for prolonged periods [ 1 , 2 ]. The incidence of venous thromboembolism (VTE) is estimated to be approximately 25% of COVID-19 patients.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Infection Complicated by a Complete Occlusion of the Left Circumflex Artery With Acute Restenosis After Drug-Eluting Stent Placement

Zaher¹,

Sattar²,

Mahmood³

et al. 2020

Cureus

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause a hypercoagulable state that can complicate the management of patients presenting with acute myocardial infarction (MI). We present the case of a patient with coronavirus disease 2019 (COVID-19) with ST elevation MI who was treated with percutaneous coronary intervention and stenting to the left circumflex artery. He was treated appropriately with anticoagulation with appropriate activated clotting time. However, the coronary angiogram course was complicated with heavy thrombosis that involved the left circumflex artery and the left anterior descending artery. Physicians are urged to suspect heparin resistance in COVID-19 patients, particularly if those patients have venous thromboembolism or acute coronary syndrome while taking heparin.

show abstract

Stent thrombosis during COVID‐19 pandemic: A case series

Montaseri

Vafa²,

Attar

et al. 2022

Clinical Case Reports

View full text Add to dashboard Cite

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China, giving rise to coronavirus disease 2019 . In March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. 1,2 Although it initially seemed that SARS-CoV-2 only affects the pulmonary system, recent studies have shown that it can also involve the cardiovascular system, gastrointestinal system, central nervous system, kidneys, and liver. 3 COVID-19 can lead to various cardiovascular complications, including myocarditis, acute myocardial

show abstract

A Case Series of Stent Thrombosis During the COVID-19 Pandemic

Cited by 48 publications

References 7 publications

A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction

A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction

COVID-19 Infection Complicated by a Complete Occlusion of the Left Circumflex Artery With Acute Restenosis After Drug-Eluting Stent Placement

Stent thrombosis during COVID‐19 pandemic: A case series

Contact Info

Product

Resources

About